228 related articles for article (PubMed ID: 38774257)
1. Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.
Nie H; Yang H; Cheng L; Yu J
J Diabetes Res; 2024; 2024():5550812. PubMed ID: 38774257
[No Abstract] [Full Text] [Related]
2. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
Gui H; Chen X; Ye L; Ma H
Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis.
Xu B; Wang L; Zhan H; Zhao L; Wang Y; Shen M; Xu K; Li L; Luo X; Zhou S; Tang A; Liu G; Song L; Li Y
J Diabetes Res; 2021; 2021():5546199. PubMed ID: 34124269
[TBL] [Abstract][Full Text] [Related]
4. Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy.
Feng S; Gao Y; Yin D; Lv L; Wen Y; Li Z; Wang B; Wu M; Liu B
Kidney Blood Press Res; 2021; 46(3):275-285. PubMed ID: 33887734
[TBL] [Abstract][Full Text] [Related]
5. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
Hu Y; Yu Y; Dong H; Jiang W
PeerJ; 2023; 11():e15437. PubMed ID: 37250717
[TBL] [Abstract][Full Text] [Related]
6. Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy.
Li B; Zhao X; Xie W; Hong Z; Cao Y; Zhang Y; Ding Y
BMC Med Genomics; 2024 May; 17(1):134. PubMed ID: 38764052
[TBL] [Abstract][Full Text] [Related]
7. Integrative analyses of biomarkers and pathways for diabetic nephropathy.
Li B; Zhao X; Xie W; Hong Z; Zhang Y
Front Genet; 2023; 14():1128136. PubMed ID: 37113991
[No Abstract] [Full Text] [Related]
8. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
Guo M; Dai Y; Jiang L; Gao J
Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
[TBL] [Abstract][Full Text] [Related]
10. Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification.
Yang J; Peng L; Tian Y; Tang W; Peng L; Ning J; Li D; Peng Y
J Immunol Res; 2022; 2022():7907708. PubMed ID: 35991124
[TBL] [Abstract][Full Text] [Related]
11. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
Chen S; Chen L; Jiang H
Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.
Zhou H; Mu L; Yang Z; Shi Y
Front Immunol; 2023; 14():1113212. PubMed ID: 36969169
[TBL] [Abstract][Full Text] [Related]
13. Identification of Key Genes of Human Advanced Diabetic Nephropathy Independent of Proteinuria by Transcriptome Analysis.
Cai F; Zhou X; Jia Y; Yao W; Lv J; Liu G; Yang L
Biomed Res Int; 2020; 2020():7283581. PubMed ID: 32685522
[TBL] [Abstract][Full Text] [Related]
14. Identification of pyroptosis-related genes and potential drugs in diabetic nephropathy.
Yan M; Li W; Wei R; Li S; Liu Y; Huang Y; Zhang Y; Lu Z; Lu Q
J Transl Med; 2023 Jul; 21(1):490. PubMed ID: 37480090
[TBL] [Abstract][Full Text] [Related]
15. Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis.
Li Z; Feng J; Zhong J; Lu M; Gao X; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():864407. PubMed ID: 35923621
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation.
Cai H; Zeng Y; Luo D; Shao Y; Liu M; Wu J; Gao X; Zheng J; Zhou L; Liu F
Genomics; 2024 Jul; 116(4):110879. PubMed ID: 38851464
[TBL] [Abstract][Full Text] [Related]
17. Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy.
Ming J; Sana SRGL; Deng X
Front Endocrinol (Lausanne); 2022; 13():978601. PubMed ID: 36329882
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
19. Screening of key biomarkers and immune infiltration in Pulmonary Arterial Hypertension via integrated bioinformatics analysis.
Zeng Y; Li N; Zheng Z; Chen R; Liu W; Cheng J; Zhu J; Zeng M; Peng M; Hong C
Bioengineered; 2021 Dec; 12(1):2576-2591. PubMed ID: 34233597
[TBL] [Abstract][Full Text] [Related]
20. GBP2 promotes M1 macrophage polarization by activating the notch1 signaling pathway in diabetic nephropathy.
Li X; Liu J; Zeng M; Yang K; Zhang S; Liu Y; Yin X; Zhao C; Wang W; Xiao L
Front Immunol; 2023; 14():1127612. PubMed ID: 37622120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
